Kite Pharma · 6 hours ago
Associate Director Global Brand Strategy & Launch Excellence
Kite Pharma is a biopharmaceutical company focused on developing innovative cancer immunotherapies. The Associate Director Global Brand Strategy & Launch Excellence will lead strategic initiatives and ensure operational excellence in the launch of cell therapy brands.
BiotechnologyHealth CareMedicalOncologyTherapeutics
Responsibilities
Co-Lead GBT Forums: Partner on multiple myeloma and lymphoma GBT forums to guide strategic decision-making and deliverables, including launch readiness milestones (LRR1-2), annual strategic planning (GSP/ISP), and global plans of action (gPOA)
Drive Launch & Operational Excellence: Optimize business processes and implement robust tracking systems to monitor milestones, metrics, and dashboards that ensure timely and high-quality execution
Ensure Strategic Alignment: Collaborate with Product Team (PT) stakeholders to synchronize long-term (10-year) product strategy with GBT’s 3-year brand strategy horizon, ensuring cohesive planning across programs
Lead Strategic Brand Initiatives: Apply deep expertise in brand strategy and launch readiness to strengthen long-term performance. Collaborate with cross-functional Global Brand Team (GBT) leads and stakeholders to align on priorities and deliver impactful outcomes
Act as a Strategic Thought Partner: Design fit-for-purpose processes and ways of working across GCS programs, driving efficiency and innovation
Develop High-Impact Communications: Create clear, compelling presentations and updates on strategy, timelines, resource needs, and critical path activities for leadership and stakeholders
Facilitate Governance & Risk Management: Prepare agendas and minutes, proactively identify risks and opportunities, and implement corrective actions to keep programs on track
Lead Key Projects & Vendor Engagement: Take ownership of priority workstreams and serve as the primary point of contact for vendor management, ensuring quality and timely deliverables
Qualification
Required
Advanced scientific degree (i.e., MD, PharmD, PhD) and 2+ years of experience OR
Master's Degree and 8+ years of experience OR
Bachelor's Degree and 10+ years of experience OR
High School Degree and 14+ years of experience
Preferred
Master's degree in science, business administration, and/or analytics
8+ years of experience in the biotech or pharmaceutical industry
5+ years of commercial launch readiness exposure or experiences in the late-stage product development life cycle
3+ years at top tier consulting firm, client-facing role
5+ years of cross-functional team management experience
Strong project management skills to produce and manage a comprehensive action tracking list, and systematically complete each task
Demonstrated analytical skills with design thinking, including proficiency in project planning tools (Smartsheet), content management tools (SharePoint), and Microsoft Office Suite (PowerPoint)
Ability to think critically and proactively with demonstrated troubleshooting and problem-solving skills
Excellent interpersonal, verbal, and written communication skills
Comfortable in a fast-paced, dynamic, and highly fluid company environment with minimal direction and able to adjust workload based upon changing priorities
Role model of Kite/Gilead core values, inspiring a high-performance culture and engagement
Benefits
Company-sponsored medical, dental, vision, and life insurance plans
Discretionary annual bonus
Discretionary stock-based long-term incentives
Paid time off
Company
Kite Pharma
Kite Pharma is a biotechnology company that designs and develops immune-based therapies to treat cancer indications.
H1B Sponsorship
Kite Pharma has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (54)
2024 (47)
2023 (54)
2022 (59)
2021 (53)
2020 (38)
Funding
Current Stage
Public CompanyTotal Funding
$335.38MKey Investors
Alta Partners
2017-08-28Acquired
2015-12-10Post Ipo Equity· $250.12M
2014-06-20IPO
Leadership Team
Recent News
BioWorld Financial Watch
2025-12-29
2025-12-07
Company data provided by crunchbase